Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
about
Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancerDisease biomarker identification from gene network modules for metastasized breast cancerPINTnet: construction of condition-specific pathway interaction network by computing shortest paths on weighted PPI.SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.Cbx8 Acts Non-canonically with Wdr5 to Promote Mammary Tumorigenesis.Lessons Learned from Mouse Mammary Tumor Virus in Animal Models.PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness.Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancerKRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.CK1δ: an exploitable vulnerability in breast cancerRoles of Wnt Target Genes in the Journey of Cancer Stem Cellsβ-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells.Comprehensive Expression Profiling and Functional Network Analysis of Porphyra-334, One Mycosporine-Like Amino Acid (MAA), in Human Keratinocyte Exposed with UV-radiation.FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma.Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro.NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades.Cancer stem cell signaling pathways.Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.Cell lineage determinants as regulators of breast cancer metastasis.Isolation, identification, and characterization of cancer stem cells: A review.Wnt signaling in triple-negative breast cancer.Wnt/beta-catenin pathway: modulating anticancer immune response.'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cellsThe different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers.A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphomaThe nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers.Expression Study and Clinical Correlations of MYC and CCAT2 in Breast Cancer Patients.Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells.Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway.Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.Breast cancer stem cells-from origins to targeted therapy.miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.The crossroads of breast cancer progression: insights into the modulation of major signaling pathways.Dually modified transmembrane proteoglycans in development and disease.The Role of Wnt Signalling in Angiogenesis.
P2860
Q26766266-F5110200-A00B-4027-AE7F-D762A0B428FFQ33682231-E508BA79-ED65-41AC-A49F-744CB5684324Q36329423-0F3553EE-5AE9-4988-A995-5850A5919C28Q36910581-9890908A-1E1C-4EBA-9727-895D2E014860Q37149776-BC90D06A-3479-4D74-8849-29F1E00F63CBQ37223750-EC4D64CC-68BD-435B-B631-F8AF9E97D21CQ37319857-1497D0D1-A80A-43EC-8C2D-7B1579AD1B39Q37346677-739BD4DD-2983-4424-B0F9-173CE7B4F29FQ37609828-3173DFC3-0095-4398-84B5-C99C47FF65DEQ37710388-7A833F4B-F178-45CD-B36E-D68C7E19560FQ38433810-67964B49-6497-4B93-8E49-D2E1AB54EA1CQ38557075-8332FAD6-9140-43D1-8F49-4D967732D3AAQ38629510-D898411F-FD86-4CF1-999B-AD5F33F031F7Q38696064-B6172F0F-A9D2-425E-91D8-E6A0ADB919B7Q38789560-593C74A6-5A35-4D5A-8AB2-C85A04EB08F1Q38796204-5CD5DC07-2121-4A72-BDC1-5B60ED5A383DQ38796628-0E7A4EDE-D4C5-4DC5-9C84-1D8E52B2D775Q38874409-53C07887-C347-4A87-AE2E-CDB84B514F15Q38950221-36B9F782-D272-40DD-9B50-1B392CD3D632Q38952268-0292518F-13FC-43D2-B74F-74067B20DC01Q39014552-A94C4915-DC5C-4DB6-B056-A9EA59B32556Q39055537-93D22409-5E41-46E0-9065-55CEA9DFF4EBQ39214992-F433C5D9-A911-46DB-8970-687897510645Q39286193-B16A1F73-88BD-4962-8FC2-F13C99824B2CQ39453727-B5422778-D82E-4370-BAC8-AE2A8AC5A7C1Q41018669-DF9D4565-A1CD-4D65-834F-60780E2E2942Q41092885-CAE7923A-C56A-48AF-8E7D-A4C6FEACBB1AQ41471175-7D45FB59-1DB9-49DD-AFB5-87524EEDCA87Q42372332-66ADC98D-CC2F-4012-B602-83392FC7664BQ42374136-D9577A8A-04E4-4D93-A089-ABC52B55F3BEQ42696721-5A2A42D1-6542-4551-9ECD-31061E69151BQ47108153-4AFF5C49-FE8E-4905-BC6F-F86DD9F93664Q47114871-4A779D40-E70A-42B6-92BC-665A4EE15F59Q47115188-67A8F132-A7EA-4CA3-B76B-AD635F41D798Q47133638-E34C4C82-A0CB-4C4D-BF1A-6E3FA2FF2B9CQ47138666-994C7D78-5E48-467A-90BD-A773042E576AQ47152122-0B1871E2-E0C8-44B2-8638-288D34E22E40Q47167746-DF927080-541A-49E7-A307-01A25584B409Q47240245-537F7729-7FF0-4591-81EF-AEAF3A2724D5Q47553825-1ED46A98-DD68-4CA3-BC9F-10F2B8B93405
P2860
Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@en
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@nl
type
label
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@en
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@nl
prefLabel
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@en
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@nl
P2093
P2860
P356
P1433
P1476
Blockade of Wnt/β-catenin sign ...... inhibiting CSC-like phenotype.
@en
P2093
Gyu-Beom Jang
Hwa-Yong Lee
In-Sun Hong
Jeong-Seok Nam
Ji-Youn Jung
Ji-Young Kim
Ki-Soo Park
Sung-Dae Cho
P2860
P2888
P356
10.1038/SREP12465
P407
P577
2015-07-23T00:00:00Z